Amgen's Multiple Myeloma Drug Shows Promise in Phase 3 Trial - Presented by: The Aol. On Network

Shares of Amgen are moving higher on Monday. The drug maker is seeing great signs in the development of treatment for multiple myeloma, a bone marrow cancer.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 17.03 0.08 ▲ 0.47%
YHOO $ 38.58 2.35 ▼ 5.74%
BABA $ 89.95 3.94 ▼ 4.20%
RAD $ 5.10 0.25 ▼ 4.67%
AAPL $ 101.089 0.13 ▲ 0.13%
SIRI $ 3.525 0.05 ▼ 1.26%
VALE $ 11.435 0.57 ▼ 4.71%
QQQ $ 99.03 0.95 ▼ 0.95%

As of 9/22/2014, 03:58 PM
More Most Active